Clinical Applications for Age Management Medicine:
Preventive Medicine and Early Interventions for Optimal Health
Thursday, November 6
7:30 am – 8:00 am
Continental Breakfast
Pre-Conference Track 1: Hormone Optimization in Women’s Health
8:00 am – 9:15 am
The Clinical Use of Estrogen, Progesterone & Testosterone in Women
Jennifer Fox Krup, M.D.
Medical Director, RejuvinAge Optimal Health & Wellness Center, Virginia Beach, VA and HB Health of Harley Street, London, UK
Visiting Physician Consultant, HB Health of Knightsbridge, London, UK
Recent studies on the use of HRT in women make it vital for clinicians to know when and how to appropriately and effectively use Estrogen, Progesterone & Testosterone as part of a comprehensive patient treatment plan for women.
9:15 am – 10:15 am
Prevention & Treatment Strategies for Female Sexual Dysfunction
Jennifer R. Berman, M.D.
Director, Berman Women’s Wellness Center, Beverly Hills, CA
Dr. Berman, a recognized expert in the field of female urology and female sexual medicine, will discuss new and emerging treatments for female sexual complaints and dysfunction including Female Sexual Arousal Disorder (FSAD). This will include the importance of a complete physical examination and physiologic evaluation of the female sexual response to detect any abnormalities in the genital region and development of treatment strategies for sexual function complaints.
10:15 am – 10:30 am
Break
10:30 am – 12:00 pm
Weight Loss and the Role of Hormonal Balance: The 8 Factors Behind Weight Loss Resistance
J.J. Virgin, Ph.D., C.N.S., C.H.F.I.
Adjunct Professor, Bauman College, Berkley, CA
Nutrition & Fitness Expert
This course provides a paradigm shift in the way that we have been trained to look at weight loss. It asks the right question, "Why is my patient overfat?"—and then discusses the role that these 8 key factors play in weight loss resistance and how to address them with your patients, so that they can overcome weight loss resistance and be lean for life.
12:00 pm – 1:15 pm
Lunch Break
1:15 pm – 2:45 pm
An Integrative Approach to Women's Health and Bio-Identical Hormone Therapy
Anna Cabeca, D.O., FACOG
Private Practice, Brunswick, GA
Clinical Instructor, Emory University, Atlanta, GA
This lecture will provide an overview and treatment strategies in the subjects of women’s wellness, age management and prevention of chronic disease. Because hormone imbalance can lead to many of the various disorders that our patients face, such as PMS, menopausal syndrome, insulin resistance, obesity, and cancer, the implementation of appropriate laboratory assessment to diagnose and create individual treatment protocols for your patients will be discussed. Included will be discussion of hormonal dosing strategies, the role of detoxification and the importance of measuring 2/16 OH Estrone ratio. Also reviewed will be nutritional and dietary strategies that are easy for patients to implement to improve their ratio. Become confident in prescribing treatment regimens and learn how to individualize your patients’ hormonal treatment protocol. Actual case studies will be discussed for clarification.
2:45 pm – 3:00 pm
Break
3:00 pm – 4:00 pm
Hormonal Treatment for Post-Menopausal Osteoporosis: Back and Forth and Back Again?
Israel Yoles, M.D.
Coordinator, The Menopausal Clinic, The Center for Women’s Health, Ashdod, Israel
Attending Physician, Sheba Medical Center, Department of OBGYN, Ashdod, Israel
Estrogen depletion during the menopause transition results in a series of events including continuous deterioration in the bone mass and bone quality leading to osteopenia, osteoporosis and ultimately, osteoporotic fractures. It is estimated that approximately 30 million women in the United States have osteoporosis and the lifetime risk of vertebral fracture for a Caucasian woman over the age of 50 is about 1 in 3, and for hip fracture, 1 in 6. This epidemic and its prevention present a major challenge to the medical community. Postmenopausal Hormonal Therapy (HT) has been demonstrated to prevent bone loss and to reduce the risk of osteoporotic fractures. Because of the beneficial effects of HT, it had been recommended not only to symptomatic women but also as a preventative treatment for osteoporosis. Beginning in 2002, several large scale studies published in the US and Europe raised some critical safety issues regarding possible association of HT with breast cancer and venous thrombo-embolism. The great enthusiasm of the medical community and the public turned toward an "anti-hormone" trend that flooded both medical and popular journals. Unfortunately, other antiresorptive treatments also have well-known side effects, leaving osteoporotic women with an uncertainty regarding the recommended safe and effective treatment. Presently, the risk/benefit pendulum has turned back in a "pro- hormone" direction, and HT is again recommended by major menopausal societies. The dilemma of whether to treat women as soon as they become osteopenic versus at the osteoporotic stage however, has not yet been solved. The questions regarding the recommended policy to prevent and treat postmenopausal osteoporosis, with which agent and for how long,will be discussed.
4:00 pm – 5:15 pm
Breast Cancer: The Hormone Connection and an Emergent View of the Future
Russell R. Roby, M.D.
Founder, Roby Institute, Austin, TX
A discussion of the history of breast cancer and the on-again, off-again connection with hormones. Current state of treatment and the many views of hormone therapy. A review of future possibilities for prevention and treatment using progesterone antagonists such as the sublingual doses used at this time to treat pain and hypersensitivity reactions.
Pre-Conference Track 2: Office-Based Aesthetic Medicine
8:00 am – 9:00 am
Clinically Treating the Aging Face and Body: Office-Based Treatments Which Have Demonstrated Evidence-Based Results
Ron Shane, Ph.D.
Research Scholar, U.C. San Diego, Department of Psychology
Post Doctoral Study, Advanced Study in UCSD’s School of Internal Medicine
The aesthetic market is flooded by numerous aesthetic and frequently financially lucrative treatments, some of which have and some of which have not demonstrated effective patient or evidence based results. An unbiased and comprehensive look at these office-based treatments will be conducted using current literature, available studies and interviews with Plastic Surgeons and Aesthetic Physicians and Practitioners.
9:00 am – 10:00 am
Clinical Treatment for Acne: Protocols and Ingredient Knowledge
Marie Piantino, L.E.
President, Co-Owner, MS Skintechnical, Phoenix, AZ
Office Based Clinicians frequently encounter patients with adult acne and must understand products, compounds and ingredients that are available for treatment including protocols for use.
10:00 am – 10:15 am
Break
10:15 am – 11:15 am
Office-Based Aesthetic Treatments for Ethnic Skin and Skin of Color: Lecture & Demonstration
Cheryl Whitman
CEO, Beautiful Forever Business Consulting
Edward M. Zimmerman, M.D.
Private Practice, Las Vegas, NV
The market for aesthetic treatment on ethnic patients or patients with skin of color is growing. The differences in equipment, products, safety and pain issues will be discussed for patients who have ethnic skin or in some cases male skin with dark pigmentation. What works best and how to provide the most effective aesthetic treatment to meet the growing demand within the ethnic and the men's market will be covered. The lecture will cover methods, techniques and clinical protocols for treatment, which may vary depending on the pigmentation of the skin.
11:15 am – 12:00 pm
Body Sculpting Using Minimally Invasive Office-Based Protocols
Mark Baily, M.D., C.M., D.A.A.P.M.
Medical Director, Kapps Professional Training
Clinic Director, Headache Treatment Clinic, Brampton, Canada
This lecture will discuss the latest safe and minimally invasive technique for removal of unwanted adipose tissue in addition to sculpting the actual body contours to the patient's desires. SA Bodysculpture uses a modified combination treatment solution and an advanced technique of permanently removing excess fat deposits in areas that are resistant to diet and exercise. The physician fills and swells the fatty areas to be removed with large volumes of special solution before the procedure. This solution completely numbs the area due to the effect of local anesthetic, therefore general anesthesia or heavy intravenous sedation is not required. At the same time, epinephrine constricts the blood vessels, reducing bleeding to negligible amounts. Fatty deposits are then removed using cannulas connected to a large bulb syringe. It is called bodysculpture because the trained physician is able to artistically sculpt the body into a new shape using delicate instruments. Besides the obvious increased safety of the procedure being performed totally under local anesthesia, there are other significant benefits. Areas can be more easily seen and multiple areas can be treated during the same session. Also, finer instruments can be used used in the tumescent bodysculpture technique allowing the physician to target specific areas with accuracy and control never before possible.
Note: This is not a lipodissolve treatment
12:00 pm – 1:15 pm
Lunch Break
1:15 pm – 2:00 pm
Advanced Injection Techniques: Soft Tissue Fillers, Part I
Mark Baily, M.D., C.M., D.A.A.P.M.
Medical Director, Kapps Professional Training
Clinic Director, Headache Treatment Clinic, Brampton, Canada
Ideally suited for physicians with some expertise in facial fillers, this presentation reviews the latest developments. Dr. Baily will discuss using fillers for cheek augmentation (Restylift™, Volumalift™), jaw line contouring, nasal shaping, eyebrow lift and the extremely popular tear trough.
2:00 pm – 2:45 pm
Advanced Injection Techniques Demonstration: Soft Tissue Fillers, Part II
Mark Baily, M.D., C.M., D.A.A.P.M.
Medical Director, Kapps Professional Training
Clinic Director, Headache Treatment Clinic, Brampton, Canada
Robert J. Troell, M.D., FACS
President, Physician & Surgeon, Beauty by Design, Las Vegas, NV
Chief Medical Officer, Brite Smile Medical & Dental Spa, Boca Raton, FL
Part II will provide attendees with an interactive demonstration of Advanced Injection Techniques as discussed showing techniques, methods and injection points.
2:45 pm – 3:00 pm
Break
3:00 pm – 4:00 pm
Laser Assisted Liposuction Procedure: Minimally Invasive Fat Removal
Robert P.K. Keller, M.D.
Medical Director & CEO, Keller Medical Institute
Medical Director & CMO, BioBanc USA
Laser assisted liposuction is a relatively new procedure approved by the FDA for the removal of small pockets of fat somewhat less invasive than traditional liposuction. Laser Lipo uses laser threads to break down fat and tighten the skin at the same time; fat is then removed using a cannula substantially smaller than used in traditional liposuction.
4:00 pm – 4:45 pm
The Use of Camouflage in Aesthetic Medicine: Lecture & Demonstration
Marie Piantino, L.E.
CEO, MS Skintechnical, Phoenix, AZ
Learn about pre- and post-treatment programs according to the type of Laser/ IPL and severity of treatment. Establish approximate time frames for wound care post treatment both in an office and homecare program. Since the introduction of more aggressive Laser/IPL treatments, there’s an increased need to provide camouflage to the patient’s post-care program. This lecture helps you understand the ideology and science behind mineral makeup—and shows the benefits and noticeable results patients will see. Discover why mineral makeup is making its entrée into the medical aesthetic market and why you should incorporate it into your practice.
4:45 pm – 5:30 pm
Combination Therapy: Microdermabrasion and Cosmetic Peels: Lecture & Demonstration
Sheila Malmanis, L.E.
President, Co-Owner, MS Skintechnical, Phoenix, AZ
Skin resurfacing using microdermabrasion and cosmetic peels as a combination therapy have evolved since their inception. Listen to a nonbiased discussion of available microdermabrasion and peel equipment, protocols and techniques that aesthetic practitioners have found effective and useful. Lecture will also provide an interactive demonstration of techniques and methods.
Friday, November 7
7:30 am – 8:00 am
Continental Breakfast
8:00 am – 8:10 am
Opening Remarks
Derrick DeSilva, Jr., M.D.
Chairman, Conference Planning Committee, Age Management Medicine Group
8:10 am – 8:30 am
Presentation of the Alan P. Mintz, M.D. Award for Excellence in Age Management Medicine, and Address
Jeffry S. Life, M.D., Ph.D.
2007 Alan P. Mintz Award Recipient
and Rabbi Yocheved Mintz
8:30 am – 9:30 am
The Effects of Obesity on Wellness: Emphasis on Prevention, Treatment and Long Term Maintenance of Weight Loss
Jay J. Garcia, M.D.
Clinical Assistant Professor of Obstetrics and Gynecology, University of South Florida, College of Medicine
Medical Director & Cofounder, Medi/Zone Weight Loss Centers, Tampa, FL
The presentation will include methods to prevent obesity and treatment of pediatric obesity, effects of obesity on chronic diseases, response of diabetic patients to weight loss, medical and behavioral modification treatments of obesity, and long-term weight maintenance programs.
9:30 am – 10:00 am
Adult Stem Cell Clinical Applications for Age Management Medicine
Connie J. Araps, Ph.D.
Vice President, Operations & Business Strategy, AssureImmune, Inc.
As the body ages, adult stem cell regenerative capacity declines and our endocrine and immune systems, tissues and organs begin to steadily deteriorate. Advanced stem cell therapies are increasingly reversing this decline. Treatment is based on the fact that adult stem cells are uniquely undifferentiated—they can become many cell types, are distributed throughout the body and are responsible for maintaining and repairing the tissue in which they reside. There are over 2000 U.S. clinical trials in progress showcasing the tremendous regenerative power of adult stem cell therapies—many of which are being used successfully to treat patients in Europe, Asia and South America. Over 11,000 patients were treated in 2006 and 2007 in the U.S. with stem cell products for orthopedic, cardiovascular, dental, aesthetic, oncologic and other indications. With the adult stem cell industry projected to grow from $40 million today to $1.5 billion by 2012 it is important for physicians to understand the clinical potential and the importance of banking cells for personalized immunological and regenerative therapies.
10:00 am – 10:30 am
Break – Visit Exhibits
10:30 am – 12:00 pm
New Clinical Protocols For The Prevention and Treatment of Alzheimer's Disease
Charles Bernick, M.D.
Medical Director, Lou Ruvo Brain Institute, Las Vegas, NV
Director, University of Nevada School of Medicine Alzheimer’s Disease Diagnostic and Treatment Centers, Las Vegas, NV
Professor of Neurology, University of Nevada School of Medicine, Las Vegas, NV
With 10 million baby-boomers predicted to get Alzheimer's disease, it is now our most feared disease, surpassing worries about heart disease and cancer. Recent research reveals that magic bullet drugs, stem cells, and vaccines are certainly not the complete answer to the prevention and treatment of Alzheimer's disease and other forms of dementia. In this presentation the 4 Pillars of Brain Longevity that are clinically effective will be unveiled. But perhaps even more significantly, startling new scanning research reveals that early memory loss, Mild Cognitive Impairment (MCI), and perhaps early Alzheimer's disease, can be impacted positively by a simple and innovative stress-relaxation exercise in only 12 minutes a day. Moreover, this research also shows how many age management issues can be helped in people practicing this easy, side-effect free, low cost approach.
12:00 pm – 1:15 pm
Lunch Break
1:15 pm – 2:15 pm
Sarcopenia; A Major Contributor to Morbidity and Mortality
Jeffry S. Life, M.D., Ph.D.
CMO, Cenegenics Medical Institute, Las Vegas, NV
Sarcopenia, the age-related loss of skeletal muscle mass, strength, and function has become a major cause of morbidity and mortality in the United States. In 2000 the direct cost of sarcopenia to our healthcare system was $18.5 billion. Sarcopenia will become an even greater burden to our society in the future as 78 million baby boomers begin to turn 65 in 2011. Sarcopenia can be prevented through the employment of age management medical strategies in individualized patient treatment plans such as hormone replacement, strength conditioning and nutrition therapy.
2:15 pm – 3:15 pm
Intervening in the Genetic Aging Program: Using The Emerging Science of Telomere Biology Today
Al Sears, M.D.
CEO, Center for Health and Wellness, Palm Beach, FL
President, Wellness Research Foundation
CEO, Primal Force Inc. & Wellness Research and Consulting, Inc.
Telomere shortening not only correlates with multiple chronic diseases associated with aging but can be shown to initiate and control changes in genetic transcription in aging cells. New discoveries demonstrate that we can currently affect this mechanism and alter aging. Evidence for telomeric control of genetic aging will be reviewed. Current strategies to slow or even reverse telomere shortening will be presented including case presentations and preliminary research data.
3:15 pm – 3:45 pm
Break – Visit Exhibits
3:45 pm – 4:45 pm
Prevention & Early Detection of Prostate Cancer: Is it Necessary to Cure Prostate Cancer When it is Possible?
Ronald Wheeler, M.D.
Medical Director, Diagnostic Center for Disease, Sarasota, FL
Dr. Wheeler will provide attendees with clinical protocols for Prostate Cancer prevention, nutrition, nutriceutical and pharmacological in nature. He will describe methods for early detection including the benefits and health risks of prostate biopsy, and discuss one of the biggest concerns with prostate health: the debate over the necessity and potential patient risk in treating slow growth prostate cancer. Attendees will be aware of the risks and contraindications to treatment or failure to treat properly.
4:45 pm – 5:45 pm
Clinical Protocols for Optimal Thyroid Health and Disease Prevention
David Brownstein, M.D.
Medical Director, Center for Holistic Medicine, West Bloomfield, MI
Thyroid disorders including hypothyroidism, hyperthyroidism, autoimmune thyroid disorders and cancer affect nearly 1 in 4 adults. This lecture will review the signs and symptoms of thyroid disorders and which tests are the most sensitive to obtain a proper diagnosis. Furthermore, ensuring proper nutrition to support the thyroid gland is essential to maintaining optimal thyroid function and preventing Thyroid disease. Dr. Brownstein will discuss the latest research about which nutrients are essential for optimizing thyroid function including the newest research on iodine.
5:45 pm – 7:15 pm
AMMG Attendee Cocktail Reception
Saturday, November 8
7:30 am – 8:00 am
Continental Breakfast
General Session, Day 2
8:00 am – 9:00 am
The Role of Endothelial Biomedicine in Inflammation and Aging
Graham Simpson, M.D.
Institute Physician, Cenegenics Medical Institute, Las Vegas, NV
Inflammation is now recognized as the underlying cause of most chronic disease and aging. The Endothelium is an expansive organ reaching to all recesses of the human body and is the primary site of this inflammation. The endothelium’s role in chronic disease and aging is largely unrecognized by clinicians. Endothelium biomedicine represents a unique opportunity for Age Management physicians to implement their preventive strategies—nutrition, exercise, hormones, nutraceuticals and detoxification and mind-body techniques to correct endothelial dysfunction, slow the aging process and reverse chronic disease.
9:00 am – 10:00 am
Non-Invasive Detection and Hormonal Benefits for Cardiovascular Disease
Robert D. Willix, Jr., M.D., FACSM
CMO/CEO, Cenegenics Medical Institute, Boca Raton, FL
There’s been a wealth of information from the non-invasive evaluation of cardiovascular disease which will be discussed during this presentation. Early detection of coronary artery disease can be accomplished through numerous non-invasive evaluations. Most recently the ultrafast CT scan of the heart has given us an imprint for calcification of the coronary arteries. Early calcification can be a predictor for non-symptomatic cardiovascular disease. One of the most exciting advances in non-invasive technology has been the combination of contrast material given intravenously simultaneously with an ultrafast CT Scanner. This new technology provides a computer animated view of the heart giving 360 degree evaluation of the coronary arteries, including estimated areas of major obstruction. This new technology lessens the need for invasive cardiac angiography and certainly is at a markedly reduced cost to the consumer. The addition of measuring physiology of the heart with studies measuring maximum oxygen consumption and oxygen pulse, the dynamic cardiac output of the heart, will be discussed. Testosterone, DHEA and growth hormone have all been shown to have receptors in the heart that respond to normal hormonal levels. The benefits of hormone replacement therapy including testosterone, DHEA, thyroid, and growth hormone to elevate IGF1 levels with IFGP3 will be presented in detail. There’s no question that low testosterone levels are now associated with an increased mortality from all cause cardiovascular disease, and therefore addressing testosterone levels in men and women may be cardio protective. Research on this will be presented.
10:00 am – 10:30 am
Break – Visit Exhibits
10:30 am – 11:30 am
Nutrients for the Prevention of Cardiovascular Disease
Derrick M. DeSilva, Jr., M.D.
Medical Teaching Faculty, John F. Kennedy Medical Center, Edison, NJ
Attending Physician/Co-Chair, Department of Complimentary Medicine, Raritan Bay Medical Center
It is NOT all about prescription medications when it comes to treating and preventing heart disease. There are a variety of cardiac nutrients that have been well studied in the field of heart disease. Nutrients such as CoQ10, Carnatine and D-Ribose, along with magnesium, have good science. These are some of the nutrients that will be discussed, along with various other issues including nutrient depletion and the role that the "next level" will bring to the treatment of the #1 killer in this country: heart disease.
11:30 am – 12:30 pm
Lunch Break
12:30 pm – 1:30 pm
The Effects of Testosterone, Prasterone and Cholecalciferol on Preventing Premature Mortality
Harvey Bartnof, M.D.
Founder and Medical Director, California Longevity & Vitality Medical Institute, San Francisco, CA
While testosterone has been FDA-approved for male hypogonadism for decades, more recently published, peer-reviewed data reveal that low testosterone is associated with premature mortality in men. Such studies are population-based, controlled ones, where mortality is primarily cardiovascular. Other studies have included the selected population of men who are treated with androgen ablation therapy for prostate carcinoma. In this group, ablation increases risk for: decline in bone mineral density; onset of diabetes mellitus and insulin resistance; and other risks of cardiovascular disease. Randomized, prospective studies of long-term testosterone replacement therapy in men with hypogonadism are lacking, but are unlikely to occur given the likely high discontinuation rate in control arms. Notwithstanding, these data suggest a newer paradigm for consideration of treating men with full and partial hypogonadism as a strategy to prevent premature mortality. Moreover, premature mortality in these men does not consider their compromised quality-of-life. The data regarding mortality in men in association with adrenopause, primarily decline in prasterone (dehydroepiandrosterone, DHEA) is scant, but suggestive of premature mortality. To date, no data have been reported to suggest a similar association for women. Recently, data has been published regarding low cholecalciferol (primarily as 25-hydroxy vitamin D) levels and premature mortality in men and women, including many conditions that increase the risks for premature mortality. However, prospective studies of replacement therapy with cholecalciferol with an end-point of mortality are lacking. The presentation will review the published studies regarding premature mortality and testosterone in men, prasterone in men and cholecalciferol in men and women.
1:30 pm – 2:45 pm
Neuro-Endocrine Balancing: Clinical Applications for the Transition Years: Peri-Menopause, Menopause & Andropause
Denise R. Mark, M.D.
Director, Monterey Bay Wellness, Carmel, CA
Medical Director, Sanesco International
The talk will describe in detail the Neuro-Endocrine Communication System and its clinical application to balancing Adrenal/Thyroid hormones and Brain Neurotransmitters in relation to each other. It will describe the “Big Six” neurotransmitters: Serotonin, GABA, Dopamine, Norepinephrine, Epinephrine and Glutamate and their relationship to the endocrine system hormones: Adrenal, Thyroid & Gonadal. The Hypothalamic-Pituitary-Adrenal-Thyroid Axis (HPA-T) as the intersection of the neuro-endocrine system will be discussed in its clinical application to balancing the brain in the transition years of peri-menopause, menopause and andropause. Integrating neurotransmitter regulation with feedback balance by the sentinel glands of the Adrenal-Thyroid axis also provides for both improved quality of life and the prevention of many of the pro-inflammatory degenerative diseases of aging.
2:45 pm – 3:15 pm
Break – Visit Exhibits
3:15 pm – 4:15 pm
FEATURED SPEAKER
Growth Hormone - Releasing Hormone and Growth Hormone Secretagogues
George R. Merriam, M.D.
Professor of Medicine, University of Washington, School of Medicine, Seattle, WA
The similarities between aging, in which GH secretion declines progressively, and adult GH deficiency (AGHD) have attracted interest in the possibility that administering or stimulating GH may confer at least some of the same benefits in aging that it does in AGHD. GH secretagogues (GHS) potentially offer both physiological and practical advantages over GH in patients in whom pituitary function is intact, since some GHS are orally active. There have been only a limited number of controlled trials of the effects GH-releasing hormone (GHRH) and ghrelin mimetic GHS in aging. These compounds are currently available for investigational use only. Most studies show increases in lean body mass, and most studies with GHRH also show reductions in body fat. Effects on physical and cognitive function have been more variable. None so far has shown effects on clinical endpoints, and none is powered to allow the assessment of beneficial vs. adverse effects. This presentation will review available studies on the effects of GH secretagogues in aging.
4:15 pm – 5:00 pm
Prescribing Hormones, Dietary Supplements, and Developments in Compounding Medications
Bill Stilling, R.Ph., M.S., J.D.
Associate Professor, University of Utah, Department of Pharacotherapy
The goal of this presentation is to provide participants with the legal framework for drugs and dietary supplements they are likely to prescribe as part of an age management medical practice and to inform participants about recent legal developments in this area.
After attending this presentation, each attendee should be able to:
1) Describe the types of medications that may be compounded under federal law and the limitations the FDA has placed on compounding.
2) Describe the legal difference between dietary supplements and drugs and the effects this legal distinction has on the ability of physicians to recommend supplements for patients.
3) Describe the legal requirements that impact prescribing testosterone, hGH, estrogens, and other hormones.
4) Implement strategies to minimize legal risks when prescribing hormones, recommending dietary supplements, and prescribing compounded medications.
5:00 pm – 5:10 pm
Update on FDA Policies and Procedures
Peter D. Rumm, M.D., MPH
Deputy Director, FDA (CDRH, Division of General, Restorative and Neurological Devices, ODE, CDRH)
Update on current FDA Policies and Procedures regarding areas of interest to Age Management Clinicians.
5:10 pm – 5:45 pm
Panel Discussion and Q & A: Legal Issues Surrounding GH and Testosterone
Peter D. Rumm, M.D., MPH
Bill Stilling, R.Ph., M.S., J.D.
Paul Heuseman, Pharm. D.
Sunday, November 9
7:30 am - 8:00 am
Continental Breakfast
General Session, Day 3
8:00 am – 9:00 am
University of Miami Retrospective Safety and Metabolic Marker 2008 Update
Enrique Ginzburg, M.D.
Professor of Surgery, University of Miami, Miller School of Medicine, Miami, FL
9:00 am – 10:00 am
Prevention of Diseases Caused by Environmental Toxins and Stress Using Nutritional and Nutriceutical Strategies
Stephen D. Nugent, N.M.D., Ph.D., P.D.D., M.A., CTN, C.N.C.
Executive Director, Complementary Health and Education, Mannatech
For the last 50 years scientists have documented a continuous decrease in the nutritional content of food. This decrease of nutrients has been consistent with the dramatic increase in environmental toxins and socio-economic stress. These factors have escalated age related diseases into our grade schools and have pushed health care to the breaking point. Each of us fits into one of five genetic categories. When we eat based upon our genetic key and then utilize the proper supplementation to augment our diet we can reverse at least eight of the ten most common biomarkers of aging. Optimal health is a process, not an event. This lecture will teach you how to utilize the genetic key diet with proper supplementation to change your health, mitigate the effects of diseases of aging, and achieve long term, sustainable, optimal health.
10:00 am – 10:30 am
Break – Visit Exhibits
10:30 am – 11:00 am
Amyloidosis in Supercentenarians: Is Prevention Possible?
L. Stephen Coles, M.D., Ph.D.
Director, Supercentenarian Research Foundation
Visiting Scholar, Department of Computer Science, UCLA
Several Supercentenarian autopsies performed in the Pathology Department at UCLA have demonstrated Systemic TTR Amyloidosis leading to congestive heart failure as the primary cause of death. Is Amyloidosis prevention necessary or even possible? Would the prevention of Amyloidosis extend the lives of those who have a genetic predisposition or manage to avoid accident and other age-related illness in the normal population?
11:00 am – 12:00 pm
FEATURED SPEAKER
Applying Cutting Edge Research; Clinical Use of Saliva Testing for Early Detection of Disease
David Wong, D.M.D., D.M.Sc
Professor & Associate Dean for Research in Dentistry, UCLA David Geffen School of Medicine
Dr. Wong and his colleagues at UCLA School of Dentistry and the Jonsson Comprehensive Cancer Center have developed a method of Saliva Testing for Disease using genetic and protein markers which have demonstrated a level of accuracy that in some instances is superior to blood testing. Saliva testing is non-invasive, shown to be extremely accurate, and can provide clinicians with an easy tool for early detection and prediction of diseases of aging, giving patients superior treatment and survivability.
12:00 pm – 1:15 pm
Lunch Break
1:15 pm – 2:00 pm
Influence of Perception: Thoughtfully Instigating Healthful Behavior Change
Cicely Valenti
Nutrition & Exercise Manager / Senior Counselor, Cenegenics Medical Institute, Las Vegas, NV
An evaluation of the physician’s role in preventive medicine to change patient behaviors by understanding how perception, logic, motivation, and choice determine behavioral outcomes.
2:00 pm – 3:00 pm
Age Management Case Presentation Series – Discussion – Q & A
Derrick M. DeSilva, Jr., M.D.
Medical Teaching Faculty, John F. Kennedy Medical Center, Edison, NJ
Attending Physician/Co-Chair Department of Complimentary Medicine, Raritan Bay Medical Center
Jeffry S. Life, M.D., Ph.D.
CMO, Cenegenics Medical Institute, Las Vegas, NV
Cicely Valenti
Nutrition & Exercise Manager / Senior Counselor, Cenegenics Medical Institute, Las Vegas, NV
Three Age Management Medicine cases selected by members of the AMMG Conference Planning Committee for presentation and discussion by the panel and conference attendees.